Author:
Czejka Martin,Kitzmüller Marie Kathrin
Publisher
Springer International Publishing
Reference48 articles.
1. Czejka MJ, Georgopoulos A. Pharmakokinetik. In: AKH Consilium der Medizinischen Universität Wien, Universimed Media Verlag, e-Book; 2006.
2. Lévi F, Karaboué A, Etienne-Grimaldi MC, Paintaud G, Focan C, Innominato P, Bouchahda M, Milano G, Chatelut E. Pharmacokinetics of irinotecan, oxaliplatin and 5-fluorouracil during hepatic artery chronomodulated infusion: a translational European OPTILIV study. Clin Pharmacokinet. 2017;56(2):165–77. [Epub ahead of print].
3. Said R, Kurzrock R, Naing A, Hong DS, Fu S, Piha-Paul SA, Wheler JJ, Janku F, Kee BK, Bidyasar S, Lim J, Wallace M, Tsimberidou AM. Dose-finding study of hepatic arterial infusion of irinotecan-based treatment in patients with advanced cancers metastatic to the liver. Investig New Drugs. 2015;33:911–2.
4. Austria Codex. Product information of drugs. Version 1.0-33e/2015 1048 A1PC07; 2016.
5. Ritschel W, Kearns G. Handbook of basic pharmacokinetics, including clinical application. 6th ed. Washington, DC: APhA; 2004.